Clincosm LogoSign in Get a demo

Advanced Hepatocellular Carcinoma

Showing 26 - 50 of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Hepatocellular Carcinoma Trial (Adebrelimab, Bevacizumab, SHR-8068)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
Jun 30, 2022

Advanced Hepatocellular Carcinoma Trial in Worldwide (Pembrolizumab/Quavonlimab, Lenvatinib, Pembrolizumab)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma
  • Pembrolizumab/Quavonlimab
  • +2 more
  • Duarte, California
  • +39 more
Jun 27, 2022

Advanced Hepatocellular Carcinoma Trial in Beijing, Xi'an (LCAR-H93T Cells)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • LCAR-H93T Cells
  • Beijing, Beijing, China
  • +2 more
Jun 11, 2022

Advanced Hepatocellular Carcinoma Trial in La Jolla (SF1126, Nivolumab)

Terminated
  • Advanced Hepatocellular Carcinoma
  • La Jolla, California
    UC San Diego Moores Cancer Center
May 11, 2022

Advanced Breast Carcinoma, Advanced Endometrial Carcinoma, Advanced Fallopian Tube Carcinoma Trial in Houston (biological, drug,

Recruiting
  • Advanced Breast Carcinoma
  • +73 more
  • Atezolizumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
May 5, 2022

Advanced Hepatocellular Carcinoma Trial (HLX07, HLX10, HLX04)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • (no location specified)
May 1, 2022

Advanced Hepatocellular Carcinoma, Hepatocellular Carcinoma, Liver Cancer Trial in Worldwide (H3B-6527)

Completed
  • Advanced Hepatocellular Carcinoma
  • +5 more
  • Los Angeles, California
  • +43 more
Apr 5, 2022

Advanced Differentiated Thyroid Gland Carcinoma, Advanced Head and Neck Carcinoma, Advanced Hepatocellular Carcinoma Trial in

Recruiting
  • Advanced Differentiated Thyroid Gland Carcinoma
  • +102 more
  • Cabozantinib S-malate
  • Nivolumab
  • Chicago, Illinois
  • +2 more
Apr 5, 2022

Advanced Hepatocellular Carcinoma Trial in Hannover (Lenvatinib, Nivolumab)

Active, not recruiting
  • Advanced Hepatocellular Carcinoma
  • Hannover, Germany
    Hannover Medical School
Mar 30, 2022

Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8 Trial

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +6 more
  • Durvalumab
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Mar 29, 2022

Advanced Hepatocellular Carcinoma Trial in Hangzhou (Envafolimab, TACE, Lenvatinib)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Mar 13, 2022

Advanced Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8 Trial

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +7 more
  • Computed Tomography
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Mar 11, 2022

Advanced Hepatocellular Carcinoma Trial in Worldwide (Enzalutamide, Placebo)

Completed
Has Results
  • Advanced Hepatocellular Carcinoma
  • San Francisco, California
  • +37 more
Feb 18, 2022

Advanced Hepatocellular Carcinoma Trial in Nanjing (SHR-1210, FOLFOX4, Placebo)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Nanjing, Jiangsu, China
    81 Hospital Nanjing
Feb 9, 2022

Advanced Hepatocellular Carcinoma, Advanced Colorectal Cancer, Advanced Gastric Cancer Trial in Hangzhou (EPCAM CAR-T)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +3 more
  • EPCAM CAR-T
  • Hangzhou, China
    First affiliated hospital, School of Medicine, Zhejiang Universi
Jan 12, 2022

Advanced Hepatocellular Carcinoma Trial in China, Taiwan (Ociperlimab, Tislelizumab, BAT1706)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Beijing, Beijing, China
  • +24 more
Nov 19, 2021

Advanced Hepatocellular Carcinoma Trial in Taipei City (Durvalumab)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Taipei City, Taiwan
    National Taiwan University Hospital
Nov 12, 2021

Advanced Hepatocellular Carcinoma Trial in Beijing (CT0181 Cells)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • CT0181 Cells
  • Beijing, Beijing, China
    Peking University
Nov 3, 2021

Advanced Hepatocellular Carcinoma Trial in Singapore (MTL-CEBPA, Atezolizumab, Bevacizumab)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Singapore, Singapore
    National University Hospital
Oct 27, 2021

Advanced Hepatocellular Carcinoma, HCC, Liver Cancer Trial in Philadelphia (PD-0332991)

Active, not recruiting
Has Results
  • Advanced Hepatocellular Carcinoma
  • +2 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Sep 21, 2021

Advanced Hepatocellular Carcinoma Trial in Japan (Cabozantinib)

Completed
  • Advanced Hepatocellular Carcinoma
  • Nagoya, Aichi, Japan
  • +16 more
Aug 25, 2021

Advanced Hepatocellular Carcinoma Trial in Hangzhou (CAR-GPC3 T Cells)

Completed
  • Advanced Hepatocellular Carcinoma
  • CAR-GPC3 T Cells
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
Aug 21, 2021

Advanced Hepatocellular Carcinoma Trial in Worldwide (PDR001, INC280)

Completed
  • Advanced Hepatocellular Carcinoma
  • Toronto, Ontario, Canada
  • +16 more
Jul 29, 2021

Advanced Hepatocellular Carcinoma Trial (Liposome-entrapped Mitoxantrone Hydrochloride Injection)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • Liposome-entrapped Mitoxantrone Hydrochloride Injection
  • (no location specified)
Jun 14, 2021

Advanced Hepatocellular Carcinoma Trial in Nanjing (Donafenib Tosilate Tablets, Toripalimab Injection)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Donafenib Tosilate Tablets
  • Toripalimab Injection
  • Nanjing, Jiangsu, China
    No.81 Hospital of PLA
Apr 30, 2021